BIT
TCRT icon

BlackRock Institutional Trust’s Alaunos Therapeutics TCRT Stock Holding History

BlackRock Institutional Trust’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16.6M Sell
20,699
-4
-0% -$3.6K ﹤0.01% 2100
2016
Q3 		$17.5M Buy
20,703
+292
+1% +$235K ﹤0.01% 1975
2016
Q2 		$16.8M Buy
20,411
+104
+0.5% +$113K ﹤0.01% 1956
2016
Q1 		$22.6M Buy
20,307
+120
+0.6% +$123K ﹤0.01% 1745
2015
Q4 		$25.2M Buy
20,187
+819
+4% +$1.35M ﹤0.01% 1701
2015
Q3 		$26.2M Buy
19,368
+1,614
+9% +$2.66M ﹤0.01% 1637
2015
Q2 		$32M Buy
17,754
+890
+5% +$1.38M 0.01% 1592
2015
Q1 		$27.2M Buy
16,864
+8,766
+108% +$13M ﹤0.01% 1735
2014
Q4 		$6.16M Buy
8,098
+1,557
+24% +$827K ﹤0.01% 2634
2014
Q3 		$2.59M Sell
6,541
-464
-7% -$224K ﹤0.01% 2961
2014
Q2 		$4.24M Sell
7,005
-773
-10% -$430K ﹤0.01% 2858
2014
Q1 		$5.34M Buy
7,778
+857
+12% +$574K ﹤0.01% 2756
2013
Q4 		$4.51M Buy
6,921
+617
+10% +$367K ﹤0.01% 2835
2013
Q3 		$3.73M Buy
6,304
+296
+5% +$133K ﹤0.01% 2857
2013
Q2 		$1.9M Buy
+6,008
New +$1.67M ﹤0.01% 3100

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Institutional Trust's TCRT Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Alaunos Therapeutics (TCRT) stake by 0.02% in Q4 2016, selling an estimated $3.6K and leaving 20,699 shares worth $16.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

BlackRock Institutional Trust first reported a position in TCRT in Q2 2013 and has held it in 15 quarters since. The position peaked at $32M in Q2 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • BlackRock Institutional Trust held 20,699 shares of Alaunos Therapeutics worth $16.6M as of Q4 2016.
  • BlackRock Institutional Trust sold 4 Alaunos Therapeutics shares in Q4 2016, an estimated $3.6K.
  • Alaunos Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2100 holding.
  • BlackRock Institutional Trust first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Alaunos Therapeutics position peaked at $32M in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.